Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Ovarian Neoplasms

  Free Subscription


06.07.2020

1 Am J Obstet Gynecol
1 Am J Surg
1 Cancer
2 Cancer Lett
1 Cancer Res
2 Clin Cancer Res
1 Eur J Obstet Gynecol Reprod Biol
8 Gynecol Oncol
1 Lancet Oncol
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Obstet Gynecol

  1. FREY MK, Ellis AE, Zeligs K, Chapman-Davis E, et al
    Impact of the COVID-19 Pandemic on Quality of Life for Women with Ovarian Cancer.
    Am J Obstet Gynecol. 2020 Jun 26. pii: S0002-9378(20)30674.
    PubMed         Abstract available


    Am J Surg

  2. LIMBACH KE, Pommier SJ, Dewey E, Leon E, et al
    Neuroendocrine metastases to the ovaries are significantly associated with small bowel neuroendocrine tumors and carcinomatosis.
    Am J Surg. 2020;219:795-799.
    PubMed         Abstract available


    Cancer

  3. GUO F, Scholl M, Fuchs EL, Berenson AB, et al
    BRCA testing in unaffected young women in the United States, 2006-2017.
    Cancer. 2020;126:337-343.
    PubMed         Abstract available


    Cancer Lett

  4. NAN X, Wang J, Cheng H, Yin Z, et al
    Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways.
    Cancer Lett. 2020;469:195-206.
    PubMed         Abstract available

  5. ALI R, Alabdullah M, Alblihy A, Miligy I, et al
    PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancers.
    Cancer Lett. 2019 Oct 24. pii: S0304-3835(19)30538.
    PubMed         Abstract available


    Cancer Res

  6. HUANG H, Wang Y, Kandpal M, Zhao G, et al
    FTO-Dependent N6-Methyladenosine Modifications Inhibit Ovarian Cancer Stem Cell Self-Renewal by Blocking cAMP Signaling.
    Cancer Res. 2020 Jun 30. pii: 0008-5472.CAN-19-4044.
    PubMed         Abstract available


    Clin Cancer Res

  7. MAY T, Oza AM
    Measurement Tool of Chemotherapy Sensitivity in Advanced Ovarian Cancer.
    Clin Cancer Res. 2020 Jun 29. pii: 1078-0432.CCR-20-1376.
    PubMed         Abstract available

  8. OZA AM, Estevez-Diz MDP, Grischke EM, Hall M, et al
    A biomarker-enriched, randomized Phase II trial of adavosertib (AZD1775) plus paclitaxel and carboplatin for women with platinum-sensitive TP53-mutant ovarian cancer.
    Clin Cancer Res. 2020 Jul 1. pii: 1078-0432.CCR-20-0219.
    PubMed         Abstract available


    Eur J Obstet Gynecol Reprod Biol

  9. PERGIALIOTIS V, Thomakos N, Frountzas M, Haidopoulos D, et al
    Perioperative blood transfusion and ovarian cancer survival rates: A meta-analysis based on univariate, multivariate and propensity score matched data.
    Eur J Obstet Gynecol Reprod Biol. 2020;252:137-143.
    PubMed         Abstract available


    Gynecol Oncol

  10. JORGE S, McFaddin AS, Doll KM, Pennington KP, et al
    Simultaneous germline and somatic sequencing in ovarian carcinoma: mutation rate and impact on clinical decision-making.
    Gynecol Oncol. 2019 Dec 27. pii: S0090-8258(19)31802.
    PubMed         Abstract available

  11. CHEN Y, Li G
    Gynecological malignancies with asymptomatic SARS-CoV-2 infection during the convalescence of outbreak.
    Gynecol Oncol. 2020 Apr 29. pii: S0090-8258(20)31019.
    PubMed        

  12. STEWART LM, Stewart CJR, Spilsbury K, Cohen PA, et al
    Association between pelvic inflammatory disease, infertility, ectopic pregnancy and the development of ovarian serous borderline tumor, mucinous borderline tumor and low-grade serous carcinoma.
    Gynecol Oncol. 2020 Jan 23. pii: S0090-8258(20)30080.
    PubMed         Abstract available

  13. MERIDETH MA, Harney LA, Vyas N, Bachi A, et al
    Gynecologic and reproductive health in patients with pathogenic germline variants in DICER1.
    Gynecol Oncol. 2020 Jan 15. pii: S0090-8258(19)31867.
    PubMed         Abstract available

  14. BEAVIS AL, Yen TT, Stone RL, Wethington SL, et al
    Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?
    Gynecol Oncol. 2020 Jan 13. pii: S0090-8258(19)31849.
    PubMed         Abstract available

  15. SIAMAKPOUR-REIHANI S, Cobb LP, Jiang C, Zhang D, et al
    Differential expression of immune related genes in high-grade ovarian serous carcinoma.
    Gynecol Oncol. 2020 Jan 7. pii: S0090-8258(19)31840.
    PubMed         Abstract available

  16. POWELL CB, Littell RD, Landen CN Jr, Pramanik S, et al
    Cytological sampling of fallopian tubes using a hysteroscopic catheter: A multi-center study.
    Gynecol Oncol. 2020;156:636-640.
    PubMed         Abstract available

  17. GORRINGE KL, Cheasley D, Wakefield MJ, Ryland GL, et al
    Therapeutic options for mucinous ovarian carcinoma.
    Gynecol Oncol. 2020 Jan 2. pii: S0090-8258(19)31836.
    PubMed         Abstract available


    Lancet Oncol

  18. BLAGDEN SP, Cook AD, Poole C, Howells L, et al
    Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial.
    Lancet Oncol. 2020;21:969-977.
    PubMed         Abstract available


    PLoS One

  19. HAILU HE, Mondul AM, Rozek LS, Geleta T, et al
    Descriptive Epidemiology of breast and gynecological cancers among patients attending Saint Paul's Hospital Millennium Medical College, Ethiopia.
    PLoS One. 2020;15:e0230625.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: